AstraZeneca PLC (LON:AZN)
13,532
+38 (0.28%)
Nov 14, 2025, 5:33 PM BST
AstraZeneca Revenue
AstraZeneca had revenue of $15.19B USD in the quarter ending September 30, 2025, with 11.99% growth. This brings the company's revenue in the last twelve months to $58.13B, up 13.52% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.
Revenue (ttm)
$58.13B
Revenue Growth
+13.52%
P/S Ratio
4.84
Revenue / Employee
$616.41K
Employees
94,300
Market Cap
209.25B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.07B | 8.26B | 18.03% |
| Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
| Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
| Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
| Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
AstraZeneca News
- 5 hours ago - Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus - Benzinga
- 11 hours ago - Health Rounds: Lilly blood thinner tops AstraZeneca's for heart procedure patients with diabetes - Reuters
- 2 days ago - Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term - Nasdaq
- 3 days ago - FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines - Reuters
- 3 days ago - AstraZeneca hits record high, cements lead as UK's biggest stock - Reuters
- 4 days ago - Why AstraZeneca Stock Was a Winner Today - The Motley Fool
- 4 days ago - AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial - Benzinga
- 4 days ago - AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial - Benzinga